Literature DB >> 6526826

Tumorigenicity of Vero cells.

I S Levenbook, J C Petricciani, B L Elisberg.   

Abstract

One of the current criteria for evaluating the acceptability of cell lines for use in vaccine production is lack of tumorigenicity. Vero cells represent an example of a class of cells known as continuous cell lines. They were derived from African green monkey kidney, and their growth properties and culture characteristics have many advantages over other cell substrates for use in vaccine production. We have tested Vero cells for tumorigenicity in nude mice and in a human muscle organ culture system, and found a significant increase in their tumorigenic potential with increasing passage numbers. Cells at passage 232 and higher produced nodules in all nude mice inoculated. Histologically the nodules were well defined, anaplastic tumors, which exhibited some of the characteristics of renal adenocarcinomas. In about 6 to 8 days all of the nodules began to regress. Data were obtained that suggested an immune mechanism was the basis for the regression phenomenon.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6526826     DOI: 10.1016/s0092-1157(84)80063-3

Source DB:  PubMed          Journal:  J Biol Stand        ISSN: 0092-1157


  12 in total

1.  Potential neoplastic evolution of Vero cells: in vivo and in vitro characterization.

Authors:  N A Andreani; S Renzi; G Piovani; P Ajmone Marsan; L Bomba; R Villa; M Ferrari; S Dotti
Journal:  Cytotechnology       Date:  2017-04-06       Impact factor: 2.058

2.  Chemical induction of endogenous retrovirus particles from the vero cell line of African green monkeys.

Authors:  Hailun Ma; Yunkun Ma; Wenbin Ma; Dhanya K Williams; Teresa A Galvin; Arifa S Khan
Journal:  J Virol       Date:  2011-05-04       Impact factor: 5.103

3.  Nonreplicating vaccinia virus vectors expressing the H5 influenza virus hemagglutinin produced in modified Vero cells induce robust protection.

Authors:  Josef Mayrhofer; Sogue Coulibaly; Annett Hessel; Georg W Holzer; Michael Schwendinger; Peter Brühl; Marijan Gerencer; Brian A Crowe; Shen Shuo; Wanjing Hong; Yee Joo Tan; Barbara Dietrich; Nicolas Sabarth; Helga Savidis-Dacho; Otfried Kistner; P Noel Barrett; Falko G Falkner
Journal:  J Virol       Date:  2009-03-11       Impact factor: 5.103

4.  Patterns of microRNA expression in non-human primate cells correlate with neoplastic development in vitro.

Authors:  Belete Teferedegne; Haruhiko Murata; Mariam Quiñones; Keith Peden; Andrew M Lewis
Journal:  PLoS One       Date:  2010-12-22       Impact factor: 3.240

5.  Hematopoietic cancer cell lines can support replication of Sabin poliovirus type 1.

Authors:  Dinja Oosterhoff; Gerard van de Weerd; Gerco van Eikenhorst; Tanja D de Gruijl; Leo A van der Pol; Wilfried A M Bakker
Journal:  Biomed Res Int       Date:  2015-02-28       Impact factor: 3.411

6.  The genome landscape of the african green monkey kidney-derived vero cell line.

Authors:  Naoki Osada; Arihiro Kohara; Toshiyuki Yamaji; Noriko Hirayama; Fumio Kasai; Tsuyoshi Sekizuka; Makoto Kuroda; Kentaro Hanada
Journal:  DNA Res       Date:  2014-09-28       Impact factor: 4.458

7.  Transformation and Tumorigenicity Testing of Simian Cell Lines and Evaluation of Poliovirus Replication.

Authors:  Silvia Dotti; Tina Lombardo; Riccardo Villa; Andrea Cacciamali; Cinzia Zanotti; Nadia Andrea Andreani; Stefano Cinotti; Maura Ferrari
Journal:  PLoS One       Date:  2017-01-03       Impact factor: 3.240

8.  Sequencing and molecular characterization of CTNCEC25, a China fixed rabies virus vaccine strain CTN-1 adapted to primary chicken embryo cells.

Authors:  Shimao Zhu; Chunhua Wang; Pei Zhang; Hui Li; Shan Luo; Caiping Guo
Journal:  Virol J       Date:  2014-10-06       Impact factor: 4.099

9.  Novel endogenous simian retroviral integrations in Vero cells: implications for quality control of a human vaccine cell substrate.

Authors:  Chisato Sakuma; Tsuyoshi Sekizuka; Makoto Kuroda; Fumio Kasai; Kyoko Saito; Masaki Ikeda; Toshiyuki Yamaji; Naoki Osada; Kentaro Hanada
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

10.  Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods.

Authors:  Yvonne E Thomassen; Olaf Rubingh; René H Wijffels; Leo A van der Pol; Wilfried A M Bakker
Journal:  Vaccine       Date:  2014-02-26       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.